Bonk Management

Management criteria checks 1/4

Bonk's CEO is Jarrett Boon, appointed in Feb 2024, has a tenure of 2.42 years. total yearly compensation is $1.79M, comprised of 16.7% salary and 83.3% bonuses, including company stock and options. directly owns 1.6% of the company’s shares, worth $185.06K. The average tenure of the management team and the board of directors is 2.4 years and 2.8 years respectively.

Key information

Jarrett Boon

Chief executive officer

US$1.8m

Total compensation

CEO salary percentage	16.73%
CEO tenure	2.4yrs
CEO ownership	1.6%
Management average tenure	2.4yrs
Board average tenure	2.8yrs

Recent management updates

Recent updates

Analysis Article • Aug 25

Health Check: How Prudently Does Safety Shot (NASDAQ:SHOT) Use Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Analysis Article • Mar 05

Is Safety Shot (NASDAQ:SHOT) Using Debt In A Risky Way?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

CEO Compensation Analysis

How has Jarrett Boon's remuneration changed compared to Bonk's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2026	n/a	n/a	-US$66m
Dec 31 2025	US$2m	US$300k	-US$69m
Sep 30 2025	n/a	n/a	-US$41m
Jun 30 2025	n/a	n/a	-US$19m
Mar 31 2025	n/a	n/a	-US$40m
Dec 31 2024	US$2m	US$150k	-US$51m

Compensation vs Market: Jarrett's total compensation ($USD1.79M) is above average for companies of similar size in the US market ($USD659.85K).

Compensation vs Earnings: Jarrett's compensation has increased whilst the company is unprofitable.

CEO

Jarrett Boon (56 yo)

2.4yrs

Tenure

US$1,793,500

Compensation

Mr. Jarrett A. Boon is Director of Yerba? Brands Corp. from June 27, 2025. Mr. Boon was Advisory Board Member of Mangoceuticals, Inc since January 06, 2023.He serves as Director at Bonk, Inc. (formerly kn...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jarrett Boon	CEO & Director	2.4yrs	US$1.79m	1.6% $ 185.1k
Mitchell Rudy	Founder	less than a year	no data	19.33% $ 2.2m
Markita Russell	Chief Financial Officer	less than a year	US$423.23k	0.12% $ 14.5k
Anthony Pedicelli	Director of Marketing	3.3yrs	no data	no data
Andy Goren	Chief Medical Officer & Member of Scientific Advisory Board	4.1yrs	no data	no data

2.4yrs

Average Tenure

53.5yo

Average Age

Experienced Management: BNKK's management team is considered experienced (2.4 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Jarrett Boon	CEO & Director	2.8yrs	US$1.79m	1.6% $ 185.1k
Mitchell Rudy	Founder	less than a year	no data	19.33% $ 2.2m
Andy Goren	Chief Medical Officer & Member of Scientific Advisory Board	5yrs	no data	no data
Hector Alila	Member of Scientific Advisory Board	3.8yrs	US$25.00k	no data
Christopher Melton	Independent Chairman of the Board	6.9yrs	US$292.00k	0.21% $ 24.9k
Jack Brewer	Member of Advisory Board	2.8yrs	no data	no data
James McAvity	Independent Director	less than a year	no data	no data
Connor Klein	Independent Director	less than a year	no data	no data
Stacey Duffy	Independent Director	less than a year	no data	no data

2.8yrs

Average Tenure

47yo

Average Age

Experienced Board: BNKK's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/06 09:25
End of Day Share Price	2026/07/02 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bonk, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Bonk Management

Management criteria checks 1/4

Key information

Recent management updates

High number of new and inexperienced directors

Bonk, Inc. Announces Resignation of John Gulyas as Executive Chairman and Board Member, Effective January 12, 2026

Bonk, Inc. Announces Resignation of Jordan Schur as President, Effective December 29, 2025

Bonk, Inc., Annual General Meeting, Dec 22, 2025

Bonk, Inc. Announces Board Appointments

Safety Shot, Inc. Announces Board Appointments

Recent updates

First quarter 2026 earnings released: US$0.23 loss per share (vs US$2.69 loss in 1Q 2025)

Full year 2025 earnings released: US$17.24 loss per share (vs US$32.60 loss in FY 2024)

High number of new and inexperienced directors

Bonk, Inc. Announces Resignation of John Gulyas as Executive Chairman and Board Member, Effective January 12, 2026

Bonk, Inc. Announces Resignation of Jordan Schur as President, Effective December 29, 2025

Bonk, Inc., Annual General Meeting, Dec 22, 2025

Bonk, Inc. announced delayed 10-Q filing

Bonk, Inc. Announces Board Appointments

Bonk, Inc. Regains Compliance with Nasdaq Listing Rules

Safety Shot, Inc. Announces Board Appointments

Safety Shot, Inc. Announces Board Changes

Safety Shot, Inc. has completed a Follow-on Equity Offering in the amount of $4.24996 million.

Safety Shot, Inc. announced that it expects to receive funding from FalconX and other investors

Safety Shot Appoints Bonk.Fun Founders, Including Mitchell Rudy, to Board with 50% Representation

Safety Shot, Inc. Announces CFO Changes

Safety Shot, Inc. has completed a Follow-on Equity Offering in the amount of $10.6 million.

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $10.6 million.

Safety Shot, Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Requirements

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $0.25 million.

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $0.25 million.

New major risk - Share price stability

Safety Shot, Inc. (NasdaqCM:SHOT) completed the acquisition Yerbaé Brands Corp. (TSXV:YERB.U).

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $0.25 million.

Safety Shot, Inc. Announces Initiation of Research and Development for Innovative New Product Lines

Safety Shot, Inc. (NasdaqCM:SHOT) completed the acquisition of Yerbaé Brands Corp. (TSXV:YERB.U).

First quarter 2025 earnings released: US$0.077 loss per share (vs US$0.33 loss in 1Q 2024)

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $0.25 million.

Full year 2024 earnings released: US$0.89 loss per share (vs US$0.48 loss in FY 2023)

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $1.288 million.

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $1 million.

New minor risk - Share price stability

Safety Shot, Inc. Reaches an Amicable Litigation Settlement Agreement, Strengthening Financial Position and Fostering Strategic Partnerships

New major risk - Shareholder dilution

Safety Shot Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price Requirement

Safety Shot, Inc. (NasdaqCM:SHOT) entered into a definitive arrangement agreement to acquire Yerbaé Brands Corp. (TSXV:YERB.U) for $14.5 million.

Safety Shot, Inc. Launches Revolutionary On-The-Go Stick Packs, Poised to Disrupt the $2 Billion Wellness Market

Independent Director exercised options and sold US$57m worth of stock

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $5 million.

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $0.49829 million.

Third quarter 2024 earnings released: US$0.21 loss per share (vs US$0.26 loss in 3Q 2023)

Safety Shot, Inc. Announces the Launch of Its Newly Rebranded and Reformulated Alcohol-Reducing Beverage, Sure Shot

Safety Shot, Inc. Rebrands as Sure Shot and Unveils a Bold New Look, Focusing on 4-Ounce Bottles and Powder Stick Packs

New major risk - Share price stability

Safety Shot, Inc. announced that it has received $3.421346 million in funding from Core 4 Capital Corp.

Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking

Health Check: How Prudently Does Safety Shot (NASDAQ:SHOT) Use Debt?

New major risk - Financial position

Safety Shot, Inc. to Release On-the-Go Powder Stick Packs of the First Alcohol Reducing Product

Safety Shot, Inc. announced that it expects to receive $1 million in funding

Safety Shot, Inc., Annual General Meeting, Jul 31, 2024

Safety Shot, Inc. Launch of Revolutionary Formula in New, Convenient 4-Ounce Bottles

First quarter 2024 earnings released: US$0.33 loss per share (vs US$0.051 loss in 1Q 2023)

Safety Shot, Inc. has filed a Follow-on Equity Offering in the amount of $4.999999 million.

New major risk - Revenue size

Full year 2023 earnings released: US$0.48 loss per share (vs US$0.70 loss in FY 2022)

Safety Shot, Inc. Appoints David J. Long to the Board of Directors

Safety Shot, Inc Appoints Jordan Schur as President and Company Board Member

Is Safety Shot (NASDAQ:SHOT) Using Debt In A Risky Way?

New minor risk - Market cap size

Safety Shot, Inc. Announces Chief Executive Officer Changes

Safety Shot, Inc. Appoints Danielle De Rosa as Chief Financial Officer, Effective March 1,2024

Less than half of directors are independent

Safety Shot Appoints Rich Pascucci to Its Board of Directors

Safety Shot, Inc. Announces West Coast Launch of Safety Shot

Safety Shot, Inc. announced delayed 10-Q filing

New major risk - Shareholder dilution

Safety Shot, Inc., Annual General Meeting, Dec 05, 2023

Safety Shot Inc. Announces Direct-To-Consumer Launch of Safety Shot

Safety Shot, Inc. Appoints Jarrett Boon to its Board of Directors